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Cost of Acute Stroke Care at a tertiary care hospital in Karachi, Pakistan
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Abstract
Objective: To evaluate cost of acute stroke care and its determinants at a tertiary care hospital in Karachi and
to find out predictors of high cost care. Acute stroke is a leading cause of morbidity and mortality. Cost of care
is the single most important determinant in availability of acute stroke care at a tertiary care hospital in Pakistan.
It is also an important factor in development of public health policies and medical insurance plans. Average
annual income in Pakistan is 4881 rupees (U$ 85).
Methods: Medical and billing records of 443 patients with acute stroke were retrospectively reviewed from 1998-
2001 at The Aga Khan University Hospital (AKUH), Karachi. Acute stroke care at AKUH usually includes routine
laboratory investigation including Lipid profile, Magnetic resonance imaging/angiography (MRI/MRA),
Echocardiogram, Carotid Doppler's ultrasound and medical management in the Stroke care unit.
Results: 443 patients were included in study. Age range was 25-98 years (Mean 58 years). 269 (61%) were
male. Length of hospital stay was 1 day; 67 patients, 2 days; 83 patients, 3 days; 70 patients, 4-5 days; 87
patients, 6-10 days; 75 patients, 11-30 days; 49 patients and more than 30 days; 12 patients. Average length of
stay was five days and median length was three days. Average total cost was 70,714 rupees (U$1179) which
included average radiology cost; 12,507 rupees (U$ 208), average laboratory cost; 8365 rupees (U$139),
average pharmacy cost; 13,320 rupees (U$222) and average bed/room charges; 27, 552 rupees (U$459).
Length of hospital stay is the most important determinant of cost. Average total cost for patients who stayed for
1 day was 19,597 rupees (U$ 326), 2-3 days; 25,568 rupees (U$426), 4-7 days; 49,705 rupees (U$828), 8-30
days; 153,586 rupees (U$2559), more than 30 days; 588,239 rupees (U$9804). Average cost for general ward
was 60,574 rupees (U$1010), private ward was 74,880 rupees (U$1248) and intensive care unit was 155,010
rupees (U$2583).
Conclusion: Cost of acute stroke care is extremely high as compared to average national income at our
hospital. Most important determinant of cost is length of hospital stay. Cost cutting measures and increased
funding from state are necessary to increase the availability of acute stroke care (JPMA 53:552;2003).
Introduction
Stroke is the leading cause of disability and third
leading cause of death in United States of America,
accounting for one in every 15 deaths.1 Stroke affects
500,000 people every year in the United States, out of which
150,000 die.2 It is the leading cause of disability; of 350,000
survivors 31% require assistance in activities of daily living,
20% require assistance in walking and 16% require
institutional care.2 Stroke is the leading cause of death in
People's Republic of China. 3 Projected incidence of stroke
is about 20000 per year in Karachi, Pakistan's largest city
with a population of about 12 million. Stroke not only
increases mortality and morbidity, but also puts a great
economic burden on the society.  Economic burden of stroke
in the US is 40.9 billion dollars per year. 4 The information
about incidence, prevalence and cost of stroke care is not
well known in Pakistan. Annual budget of Pakistan is 742
billion rupees and proportion of health budget is 135 million
rupees (1.8% of budget). Average annual income of an
individual is 4881 rupees (USD 85) in Pakistan.5
State of the art acute stroke care is a specialized care
which not only requires a well equipped facility but trained
neurologists and a coordinated effort with other departments
like radiology and cardiology. Due to severe budget
constraints public health facilities are not capable of
providing this specialized care. There are only a few private
hospitals in Karachi, which are equipped to provide acute
stroke care. Cost of care is the single most important
determinant in patients' ability to access acute stroke care at
a private, tertiary care hospital in Pakistan. Cost analysis is
an important factor in development of public health policies
and medical insurance plans. Our objective was to
determine cost of acute stroke care and its determinants at
tertiary care center in our country. This information may
help the governmental policy makers and non-governmental
organizations to develop health care plans and budget
modifications to prevent loss of manpower and minimize
economic burden on the society.
Patients and Methods
Patients with diagnosis of acute stroke over a period
of four years (1998-2001) were identified through ICD-9
coding system of the hospital medical records. Their
medical and billing records were reviewed retrospectively.
The data regarding demographics, length of hospital stay
and cost of various investigations (laboratory and
radiological), drugs and bed/room were recorded and
analyzed. Acute stroke care at our hospital usually include
routine laboratory investigations such as complete blood
count (CBC), biochemistry (serum sodium, potassium, liver
enzymes and lipid profile), coagulation profile (PT and
aPTT), electrocardiogram (EKG), echocardiogram, carotid
Doppler ultrasound, neuroimaging of brain (CT scan, MRI
scan or both) and medical management in stroke care unit.
The data was analyzed by using statistical package for social
sciences version 10 (SPSS 10.0). The data is presented in
frequencies, percentages and means with standard deviation.
In addition chi square test was used to see association
between various variables and cost of the care.  
Results
Four hundred forty three patients were identified.
Age range was 25-98 years (mean 58 years). Two hundred
sixty nine (61%) were men and 174 (39%) were women.
Average length of stay was five days and median length of
stay was three days (range 1- 68 days). Length of stay for
307 patients (70%) was less than 6 days while 220 patients
(71%), stayed in hospital for just 3 days. Only 12 patients
(3%) stayed in hospital for more than one month (Table 1).   
Average total cost of the care was 70,714 Pak rupees
(US$ 1179) which included average radiology cost; 12,507
rupees (U$ 208), average laboratory cost; 8365 rupees
(U$139), average pharmacy cost; 13,320 rupees (U$222)
and average bed/room charges; 27,552 rupees (U$459).
Bulk of the cost i.e., 39% was incurred by hospital
bed/room charges and pharmacy, radiological investigations
and laboratory investigations accounted for 19%, 18% and
12% respectively. 
The average total cost was directly related to length
of hospital stay (Table 2). Average laboratory and pharmacy
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Table 1. Length of hospital stay.
S. No. Length of hospital Number of 
stay (days) patients*
1 1 67 (15)
2 2 83 (19)
3 3 70 (16)
4 4-5 87 (20)
5 6-10 75 (17)
6 11-30 49 (11)
7 >30 12 (3)
* Percentages in parenthesis
Table 2. Total cost* (mean) of care in relation to length of hospital stay^.
S. No LOS (days) ALC APC ARC TAC
1 1 3272 (55) 1743 (29) 9148 (152) 19,597 (326) 
2 2-3 3446 (57) 2134 (36) 10968 (182) 25,568 (426) 
3 4-7 6504 (108) 11732 (196) 12151 (203) 49,705 (828) 
4 8-30 17,404 (290) 32258 (538) 15074 (251) 153,586 (2559) 
5 >30 59,298 (988) 160291 (2672) 35510 (592) 588,239 (9804) 
* cost in Pak Rupees (US$ in parenthesis)
^USD= US Dollars,       LOS= Length of hospital stay in days,        TAC= Total average cost of care,        ALC= Average laboratory cost, 
Average pharmacy cost,        ARC= Average radiology cost
cost was also significantly higher in patients who stayed
longer (Table 2). Though the average radiology cost was
higher in the patients who stayed longer, however the
difference was not as significant as that of the laboratory
and pharmacy cost (Table 2). The cost was also higher in
patients, who were admitted to intensive care unit (Table 3).
The cost of the care for patients who were admitted to
private ward was also higher as compared to those who
were admitted to general ward (Table 3).
Discussion
Cost of care for any medical problem is an extremely
important issue for developing countries. The issue is more
important for our country for two reasons i.e. our resources
are limited and our health system is mainly based on self-
financing. In the absence of a functional state health system
and without widespread third-party payers, patients bear
medical costs out of pocket. The impact of knowing cost of
care for a problem like stroke (in acute settings) and its
determinants would be profound, as this would not only
help governmental as well as nongovernmental
organizations including insurance agencies to design health
policies and also help explore options for cutting the cost of
acute care. This would also help in developing strategies for
primary and secondary prevention from this deadly disease. 
Stroke care has a high economic burden. This
economic burden is directly related to long-term disability
associated with stroke. It is well known that improved acute
stroke care is not only associated with decreased long-term
disability but it has a beneficial impact on economic burden
related to stroke. 6-9 The reported cost of acute stroke care is
variable and is related to the length of hospital stay.10-12 Our
study also found that the cost of care was higher in patients
who stayed longer i.e., cost was increased by 30 times in
patients who stayed for more than a month as compared to
those who stayed for one day (Table 2). However, the long
hospital stay could probably relate to severity of the stroke. 
In North America the average cost of acute stroke
care per discharge/patient is variably reported as US$10,740
- 13,149.13,14 A study from Singapore12 reported relatively
lower cost for the care i.e., U$ 7542 as compared to North
America, however this is substantially high as compared to
total average expenditure for the care at our center i.e.,
70,714 rupees (U$ 1179). The reasons for relatively lower
cost at our center are probably lower cost for the
neuroimaging and bed/room charges, and relatively shorter
hospital stay. Relatively shorter hospital stay at our hospital
is probably due to great emphasis on outpatient or home
based rehabilitation as compared to inpatient rehabilitation
in Singapore or North America.
Though we did not compute the costs for different
types of stroke but it has been reported that the cost of acute
stroke care is higher for hemorrhage as compared to
ischemic strokes11,12,15 and within the category of ischemic
strokes the cost was high for nonlacunar infarctions as
compared to lacunar infarction.12
At our center bulk of the cost i.e. 39% was incurred
by hospital bed/room charges including physician's fee.
Venketasubramanian et al12 reported 48.5% of the total cost
was shared by these charges. Cost of radiological
investigations and medications was 19% and 12%
respectively at our center as compared to 15 % and 8 % in
Singapore.12 The hospital bed charges were reported to be
as high as 95% of the total charges for acute care of transient
ischemic attacks in Canada.16
We do not know the exact cost of acute stroke care at
other tertiary care centers in our country but it would be
variable from center to center depending on the extent of
evaluation and interventions. However, it would be lower at
the centers in public sector at least by about 50%, as the
hospital bed charges and physician's fee is nominal. The
cost at other centers in private sector might be more or less
similar provided that extent of evaluation and intervention
is similar.
At our center average cost of acute stroke care per
patient is high as compared to per capita income in Pakistan.
Most important determinant of the cost is length of hospital
stay so decreasing the stay by expediting the evaluation and
rehabilitation would reduce the cost to some extent,
however, increased funding from the state is necessary to
increase the availability of the care.
Considering our limited resources, need of
preventive strategies should be emphasized. Secondary
prevention of stroke is mainly based on antiplatelet therapy
and at best these drugs reduce recurrence by 16-37%.17,18
Hypertension is the single most important modifiable risk
factor for hemorrhagic as well as ischemic stroke19 and it
has been shown that every decrease in diastolic blood
pressure of 7.5 mm Hg is associated with 46% reduction in
stroke. 20 Diabetes mellitus and high cholesterol are other
important modifiable risk factors for ischemic stroke. These
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Table 3. Total average cost of the care in relation to hospital locality.
S. No. Locality Total average cost 
of care (Rupees)*
1 Intensive care unit 155010 (3583.5)
2 Private ward 74881 (1248)
3 General ward 60574 (1010)
* In parenthesis: Cost in US$ 
increase the risk of stroke by 1.5 to 321 and 1-2 folds
respectively.22 Every third person above age of 45 years in
Pakistan has hypertension and every fourth person in the
age group has diabetes mellitus. 23 Prevalence of
hypercholestremia is 12.6% in persons above age of 15
years (and the frequency is as high as 33% in women of age
above 65 years).23 These facts underscore the need of
utilization of the resources in identifying and aggressive
control of the risk factors and education of the masses in this
regard.
We believe that social and economic burden of
stroke can be greatly reduced by providing state of the art
care to acute stroke patients. Increased availability of this
care is largely dependent on subsidized cost of this care.
Measures are to be taken by Governmental health agencies
and policy makers to subsidize cost of acute care, in order
to increase availability of acute stroke care. 
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